Rivaroxaban Cuts Recurrent Blood Clots in Obese Patients

MONDAY, Sept. 30, 2019 -- Real-world evidence shows that rivaroxaban reduces the risk for recurrent venous thromboembolism (VTE) in morbidly obese patients, with similar safety and efficacy as warfarin, according to a study published in the October...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news